High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event

Leukemia

Volumn 25, Issue 3, 2011, Pages 515-526

  Quere R ^a   Andradottir, S ^a   Brun, A C M ^a   Zubarev, R A ^b   Karlsson, G ^a   Olsson, K ^a   Magnusson, M ^a   Cammenga, J ^a   Karlsson, S ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

acute myeloid leukemia; CD44; homeobox; HOXA10; leukemia addiction; leukemia initiating cells

Indexed keywords

HERMES ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER GENETICS; CANCER GROWTH; CANCER TRANSPLANTATION; CELL POPULATION; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFORMATION; HOXA10 GENE; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 79952448517     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.281     Document Type: Article

References (47)

1. Lawrence HJ, Sauvageau G, Humphries RK, Largman C. The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem cells (Dayton, OH) 1996; 14: 281-291. . (Pubitemid 26161610)
2. Magli MC, Barba P, Celetti A, De Vita G, Cillo C, Boncinelli E. Coordinate regulation of HOX genes in human hematopoietic cells. Proc Natl Acad Sci USA 1991; 88: 6348-6352. . (Pubitemid 21914943)
3. Magli MC, Largman C, Lawrence HJ. Effects of HOX homeobox genes in blood cell differentiation. J Cell Physiol 1997; 173: 168-177. . (Pubitemid 27481125)
4. Andreeff M, Ruvolo V, Gadgil S, Zeng C, Coombes K, Chen W et al. HOX expression patterns identify a common signature for favorable AML. Leukemia 2008; 22: 2041-2047. .
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (New York, NY) 1999; 286: 531-537. .
6. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 1999; 13: 687-698. . (Pubitemid 29243618)
7. Borrow J, Shearman AM, Stanton Jr VP, Becher R, Collins T, Williams AJ et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996; 12: 159-167. . (Pubitemid 26051296)
8. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 1996; 12: 154-158. . (Pubitemid 26051295)
9. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714-3725. . (Pubitemid 28327389)
10. Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, Sauvageau G. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol Cell Biol 1999; 19: 6355-6366. . (Pubitemid 29399340)
11. Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 1997; 17: 495-505. . (Pubitemid 26425639)
12. Kroon E, Thorsteinsdottir U, Mayotte N, Nakamura T, Sauvageau G. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. EMBO J 2001; 20: 350-361. . (Pubitemid 32126971)
13. Pineault N, Abramovich C, Ohta H, Humphries RK. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 2004; 24: 1907-1917. . (Pubitemid 38248932)
14. Shen WF, Montgomery JC, Rozenfeld S, Moskow JJ, Lawrence HJ, Buchberg AM et al. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol Cell Biol 1997; 17: 6448-6458. . (Pubitemid 27451190)
15. Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 1999; 19: 3051-3061. . (Pubitemid 29144550)
16. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001; 21: 224-234. .
17. Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009; 113: 2375-2385. .
18. Horton SJ, Walf-Vorderwulbecke V, Chatters SJ, Sebire NJ, de Boer J, Williams O. Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities. Blood 2008; 113: 4922-4929. .
19. Buske C, Feuring-Buske M, Antonchuk J, Rosten P, Hogge DE, Eaves CJ et al. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood 2001; 97: 2286-2292. . (Pubitemid 32291473)
20. Magnusson M, Brun AC, Miyake N, Larsson J, Ehinger M, Bjornsson JM et al. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 2007; 109: 3687-3696. . (Pubitemid 46641717)
21. Roumier C, Lejeune-Dumoulin S, Renneville A, Goethgeluck AS, Philippe N, Fenaux P et al. Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients. Leukemia 2006; 20: 433-436. . (Pubitemid 43291740)
22. Schneider F, Bohlander SK, Schneider S, Papadaki C, Kakadyia P, Dufour A et al. AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia. Leukemia 2007; 21: 2199-2201. . (Pubitemid 47423813)
23. Valk PJ, Bowen DT, FrewME, Goodeve AC, Lowenberg B, Reilly JT. Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16). Haematologica 2004; 89: 106. . (Pubitemid 38165863)
24. Wang YY, Zhou GB, Yin T, Chen B, Shi JY, Liang WX et al. AML1- ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA 2005; 102: 1104-1109. . (Pubitemid 40170733)
25. Grisolano JL, O'Neal J, Cain J, Tomasson MH. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci USA 2003; 100: 9506-9511. . (Pubitemid 37033958)
26. Palmqvist L, Argiropoulos B, Pineault N, Abramovich C, Sly LM, Krystal G et al. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. Blood 2006; 108: 1030-1036. . (Pubitemid 44154641)
27. Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 2005; 115: 2159-2168. . (Pubitemid 41134157)
28. Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001; 98: 10398-10403. . (Pubitemid 32803031)
29. Bjornsson JM, Andersson E, Lundstrom P, Larsson N, Xu X, Repetowska E et al. Proliferation of primitive myeloid progenitors can be reversibly induced by HOXA10. Blood 2001; 98: 3301-3308. .
30. Nielsen ML, Savitski MM, Zubarev RA. Improving protein identification using complementary fragmentation techniques in Fourier transform mass spectrometry. Mol Cell Proteomics 2005; 4: 835-845. . (Pubitemid 40873012)
31. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABLexpressing leukemic stem cells. Nat Med 2006; 12: 1175-1180. . (Pubitemid 44527353)
32. Legras S, Gunthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans HC et al. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 1998; 91: 3401-3413. . (Pubitemid 28193893)
33. Bendall LJ, Bradstock KF, Gottlieb DJ. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia 2000; 14: 1239-1246. . (Pubitemid 30445031)
34. Erkeland SJ, Verhaak RG, Valk PJ, Delwel R, Lowenberg B, Touw IP. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia. Cancer Res 2006; 66: 622-626. . (Pubitemid 43165920)
35. Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, Shannon KM et al. A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood 2009; 113: 1075-1085. .
36. Touw IP, Erkeland SJ. Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia. Mol Ther 2007; 15: 13-19. . (Pubitemid 46043644)
37. Goverdhana S, Puntel M, Xiong W, Zirger JM, Barcia C, Curtin JF et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther 2005; 12: 189-211. . (Pubitemid 41025089)
38. Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 2005; 105: 324-334. . (Pubitemid 40053100)
39. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; 20: 5695-5707. . (Pubitemid 32928107)
40. Rhoades KL, Hetherington CJ, Harakawa N, Yergeau DA, Zhou L, Liu LQ et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 2000; 96: 2108-2115. .
41. Yuan W, Payton JE, Holt MS, Link DC, Watson MA, DiPersio JF et al. Commonly dysregulated genes in murine APL cells. Blood 2007; 109: 961-970. . (Pubitemid 46220640)
42. Staber PB, Linkesch W, Zauner D, Beham-Schmid C, Guelly C, Schauer S et al. Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene 2004; 23: 894-904. . (Pubitemid 38250934)
43. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003; 4: 216. .
44. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106: 1901-1910. . (Pubitemid 41291700)
45. Stefanidakis M, Koivunen E. Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 2006; 108: 1441-1450. . (Pubitemid 44316107)
46. Redondo-Munoz J, Ugarte-Berzal E, Terol MJ, Van den Steen PE, Hernandez Del Cerro M, Roderfeld M et al. Matrix metalloproteinase-promotes chronic lymphocytic leukemia B cell survival through its hemopexin domain. Cancer Cell 2010; 17: 160-172.
47. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-1174. (Pubitemid 44527352)